Compedia Global Healthcare
Compedia Global Healthcare develops AI-powered digital therapeutics for ADHD, autism, PTSD, anxiety, and chronic disease management.
Problem & solution
Clinics and health systems need scalable, personalized ways to treat ADHD, autism, PTSD, anxiety, and chronic disease. Compedia's clinically validated, AI-powered digital therapeutics platform is designed to help them deliver that care at scale while supporting FDA and reimbursement pathways.
Primary customers & users
Clinics and health systems delivering care for ADHD, autism, PTSD, anxiety, and chronic disease management.
Differentiation
Builds on decades of digital health experience, proven research partnerships with leading universities, and a track record of successful commercialization of evidence-based healthcare solutions.
Current traction
Currently in pilot / early clinical validation, pre-seed and bootstrapped to date, with research partnerships with leading universities underpinning its evidence base.
How Summit participants can help
We hope to establish strategic partnerships with U.S. healthcare providers, insurers, investors, and research organizations, validate our commercialization and reimbursement strategy, and identify pilot opportunities that will accelerate FDA readiness and adoption of our AI-powered digital therapeutics platform.